Technology Strategy Board

A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.

The UK Technology Strategy Board (TSB) will invest £39.5 million across six calls in the next six months, in areas from regenerative medicine to low carbon housing.

The UK Technology Strategy Board is going halves with industry on projects that aim to capture difficult or complex environments such as on the sea bed.